KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Finished Goods (2016 - 2019)

Jazz Pharmaceuticals has reported Finished Goods over the past 10 years, most recently at $22.3 million for Q1 2019.

  • Quarterly results put Finished Goods at $22.3 million for Q1 2019, changed N/A from a year ago — trailing twelve months through Mar 2019 was $22.3 million (changed N/A YoY), and the annual figure for FY2018 was $21.3 million, down 11.22%.
  • Finished Goods for Q1 2019 was $22.3 million at Jazz Pharmaceuticals, up from $21.3 million in the prior quarter.
  • Over the last five years, Finished Goods for JAZZ hit a ceiling of $24.0 million in Q4 2017 and a floor of $5.0 million in Q4 2015.
  • Median Finished Goods over the past 5 years was $17.9 million (2018), compared with a mean of $16.0 million.
  • Biggest five-year swings in Finished Goods: crashed 69.83% in 2015 and later surged 175.91% in 2016.
  • Jazz Pharmaceuticals' Finished Goods stood at $5.0 million in 2015, then surged by 175.91% to $13.8 million in 2016, then soared by 73.8% to $24.0 million in 2017, then decreased by 11.22% to $21.3 million in 2018, then grew by 4.68% to $22.3 million in 2019.
  • The last three reported values for Finished Goods were $22.3 million (Q1 2019), $21.3 million (Q4 2018), and $17.9 million (Q2 2018) per Business Quant data.